Plasma Metabolic Signature and Abnormalities in HIV-Infected Individuals on Long-Term Successful Antiretroviral Therapy
Authors:
Open Access
- 30 September 2019
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 9 (10) , 210
Abstract
Targeted metabolomics studies reported metabolic abnormalities in both treated and untreated people living with human immunodeficiency virus (HIV) (PLHIV). The present study aimed to understand the plasma metabolomic changes and predicted the risk of accelerated aging in PLHIV on long-term suppressive antiretroviral therapy (ART) in a case-control study setting and its association with the plasma proteomics biomarkers of inflammation and neurological defects. Plasma samples were obtained from PLHIV on successful long-term ART for more than five years (n = 22) and matched HIV-negative healthy individuals (n = 22, HC herein). Untargeted metabolite profiling was carried out using ultra-high-performance liquid chromatography/mass spectrometry/mass spectrometry (UHPLC/MS/MS). Plasma proteomics profiling was performed using proximity extension assay targeting 184 plasma proteins. A total of 250 metabolites differed significantly (p < 0.05, q < 0.1) between PLHIV and HC. Plasma levels of several essential amino acids except for histidine, branched-chain amino acids, and aromatic amino acids (phenylalanine, tyrosine, tryptophan) were significantly lower in PLHIV compared to HC. Machine-learning prediction of metabolite changes indicated a higher risk of inflammatory and neurological diseases in PLHIV. Metabolic abnormalities were observed in amino-acid levels, energetics, and phospholipids and complex lipids, which may reflect known differences in lipoprotein levels in PLHIV that can resemble metabolic syndrome (MetS).Keywords
Funding Information
- Vetenskapsrådet (2017-01330, 2018-06156)
This publication has 33 references indexed in Scilit:
- Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapyScientific Reports, 2018
- HIV/HAART-associated oxidative stress is detectable by metabonomicsMolecular BioSystems, 2017
- Prevalence of Metabolic Syndrome Among People Living with HIV in Developing Countries: A Systematic ReviewAIDS Patient Care and STDs, 2017
- Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to TreatmentPLOS ONE, 2016
- HIV infection induces structural and functional changes in high density lipoproteinsAtherosclerosis, 2015
- Future challenges for clinical care of an ageing population infected with HIV: a modelling studyThe Lancet Infectious Diseases, 2015
- High prevalence of metabolic syndrome among urban subjects in India: A multisite studyDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2014
- Nevirapine–Raltegravir Combination, An Nrti and Pi/R Sparing Regimen, as Maintenance Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected PatientsAntiviral Therapy, 2014
- Long-Term Efficacy of First Line Antiretroviral Therapy in Indian HIV-1 Infected Patients: A Longitudinal Cohort StudyPLOS ONE, 2013
- HIV Infection, Inflammation, Immunosenescence, and AgingAnnual Review of Medicine, 2011